ASO Visual Abstract: Larger Tumor Size and Elevated Serum Chromogranin A Levels Predict Metastatic Disease on DOTATATE Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors

被引：0

|

作者：

Labora, Amanda ^{[1
]}

Shimizu, Takayuki ^{[1
]}

Moore, Alexandra ^{[1
]}

Premji, Alykhan ^{[1
]}

Armstrong, Wesley R. ^{[2
]}

Chen, Kevin Y. ^{[2
]}

Link, Jason ^{[1
]}

Chan, Charlotte S. ^{[1
]}

Allen-Aurbach, Martin S. ^{[3
]}

Donahue, Timothy R. ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90033 USA

[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA

[3] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Ahmanson Translat Theranost Div, Los Angeles, CA USA

来源：

ANNALS OF SURGICAL ONCOLOGY | 2025年 / 32卷 / 02期

关键词：

D O I：

10.1245/s10434-024-15740-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：1197 / 1198

页数：2

相关论文

共 23 条

[21] The contribution of combined imaging based on volumetric parameters with Ga-68 DOTA-TATE and F-18 FDG PET/CT in neuroendocrine tumors; comperative study with tumor proliferation indexes and serum chromogranin-A levels
Abdulrezzak, Ummuhan
JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
[22] Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocrine tumors
Amir Sabet
James Nagarajah
Ahmet Semih Dogan
Hans-Jürgen Biersack
Amin Sabet
Stefan Guhlke
Samer Ezziddin
EJNMMI Research, 3
[23] Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocrine tumors
Sabet, Amir
Nagarajah, James
Dogan, Ahmet Semih
Biersack, Hans-Juergen
Sabet, Amin
Guhlke, Stefan
Ezziddin, Samer
EJNMMI RESEARCH, 2013, 3 : 1 - 6